These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 21530386

  • 1. False-negative serology in patients with acute parvovirus B19 infection.
    Bredl S, Plentz A, Wenzel JJ, Pfister H, Möst J, Modrow S.
    J Clin Virol; 2011 Jun; 51(2):115-20. PubMed ID: 21530386
    [Abstract] [Full Text] [Related]

  • 2. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Söderlund-Venermo M, Hedman K.
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [Abstract] [Full Text] [Related]

  • 3. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M.
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [Abstract] [Full Text] [Related]

  • 4. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF, Claas EC, Sopaheluakan T, Kroes AC.
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [Abstract] [Full Text] [Related]

  • 5. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI, Enders M, Motz M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Sep; 52(7-8):362-5. PubMed ID: 16316402
    [Abstract] [Full Text] [Related]

  • 6. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
    Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, Modrow S.
    J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
    [Abstract] [Full Text] [Related]

  • 7. [Diagnostic tests: Human parvovirus B19].
    Nunoue T.
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():329-31. PubMed ID: 16111265
    [No Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S.
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
    Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S.
    Clin Infect Dis; 2009 Dec 01; 49(11):1660-6. PubMed ID: 19863443
    [Abstract] [Full Text] [Related]

  • 10. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
    Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ.
    J Gastroenterol Hepatol; 2005 May 01; 20(5):733-8. PubMed ID: 15853987
    [Abstract] [Full Text] [Related]

  • 11. Human parvovirus B19 in cord blood of premature infants.
    Koga M, Matsuoka T, Katayama K, Takeda K, Nakata M, Sase M, Kato H, Furukawa S.
    Am J Perinatol; 2001 Aug 01; 18(5):237-40. PubMed ID: 11552176
    [Abstract] [Full Text] [Related]

  • 12. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection.
    Kok RH, Wolfhagen MJ, Klosters G.
    Clin Infect Dis; 2001 Jan 15; 32(2):311-2. PubMed ID: 11170925
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    Opaleye OO, Fagbami AH, Lalremruata A, Kun JF.
    J Med Virol; 2011 Apr 15; 83(4):710-6. PubMed ID: 21328387
    [Abstract] [Full Text] [Related]

  • 14. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
    Escher F, Modrow S, Sabi T, Kühl U, Lassner D, Schultheiss HP, Noutsias M.
    Med Sci Monit; 2008 Dec 15; 14(12):CR589-97. PubMed ID: 19043365
    [Abstract] [Full Text] [Related]

  • 15. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
    Gallinella G, Zuffi E, Gentilomi G, Manaresi E, Venturoli S, Bonvicini F, Cricca M, Zerbini M, Musiani M.
    J Med Virol; 2003 Sep 15; 71(1):135-9. PubMed ID: 12858419
    [Abstract] [Full Text] [Related]

  • 16. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
    Weseslindtner L, Aberle JH, Hedman L, Hedman K.
    J Infect Dis; 2017 Jan 15; 215(2):214-220. PubMed ID: 27789725
    [Abstract] [Full Text] [Related]

  • 17. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.
    Dieck D, Schild RL, Hansmann M, Eis-Hübinger AM.
    Prenat Diagn; 1999 Dec 15; 19(12):1119-23. PubMed ID: 10590428
    [Abstract] [Full Text] [Related]

  • 18. [Parvovirus B19 infection: diagnosing and treating a kidney transplant patient].
    León LR, Curcio D, Casadei D.
    Nefrologia; 2010 Dec 15; 30(6):704. PubMed ID: 21113225
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
    Braham S, Gandhi J, Beard S, Cohen B.
    J Clin Virol; 2004 Sep 15; 31(1):5-10. PubMed ID: 15288606
    [Abstract] [Full Text] [Related]

  • 20. Serological study of parvovirus B19 infection in women with recurrent spontaneous abortions.
    Kishore J, Gupta I.
    Indian J Pathol Microbiol; 2006 Oct 15; 49(4):548-50. PubMed ID: 17183849
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.